C2 -CORVUS Cholesterol-Control (C2) Controlled Targets for High Vascular Risk Patients Using effective Statins (CORVUS) - C2 -CORVUS
Study identifier:NIS-CHU-DUM-2009/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
C2 -CORVUS Cholesterol-Control (C2) Controlled Targets for High Vascular Risk Patients Using effective Statins (CORVUS)
Medical condition
cardiovascular risk
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
1500
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 May 2009
Primary Completion Date: -
Study Completion Date: 01 Nov 2009
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Patients at high cardiovascular risk | - |
Contacts
Investigators
Principal Investigator
Mark Laszlo
County Hospital Bekes, Gyula
